ASX-listed brain scanner company EMVision has announced that its First Responder Proof-of-Concept (PoC) device has been put through a series of volunteer scans in remote settings, in collaboration with the Royal Flying Doctor Service (RFDS) and the Australian Stroke Alliance. In a statement on Wednesday, the company shared that RFDS staff had received preliminary training…
Brain imaging company EMVision Medical Devices has revealed what it called ‘exceptional’ results for its world-first emu scanner to identify stroke and stroke type. In total 307 participants were enrolled in the EMView trial and scanned with the EMVision emu brain scanner (pictured) at Liverpool Hospital, Royal Melbourne Hospital and the Princess Alexandra Hospital, including…
In the latest of our series of webinars on important topics, we will be looking at the unavoidable rise in artificial intelligence and what enterprises are doing to ensure they aren’t left behind. @AuManufacturing and Softlabs are proud to present Mfg and AI – the how and why, to air on Aug 14 at 11:00…
Medical imaging manufacturer EMVision Medical Devices has reported positive interim analysis from the latest clinical trials of its lightweight stroke imager. The multi-site clinical trials were focused on developing EMVision’s neurodiagnostic AI algorithms to aid in the diagnosis of suspected haemorrhagic or ischaemic stroke. EMVision is one of two Australian companies developing lightweight imaging devices…
Imaging company EMVision Medical Devices is preparing for a meeting with the US Food and Drug Administration as it edges closer to seeking approval to market its emu point of care scanner to detect stroke. The company has been developing a system that uses microwaves and AI in a machine small enough to fit in…
US technology company Keysight Technologies has taken a strategic stake worth $15.28 million in medical imaging company EMVision. In a statement on Thursday, EMVision said the investment represented a significant milestone, and would accelerate commercialisation of the portable brain scanner emu, its first product. Keysight will be issued 7,454,231 new ordinary shares at $2.05 per…
What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Ukraine war propels DroneShield to new records War brings no good to anyone but a few military contractors which boom during times of rising tensions – none more so than drone detection and countermeasure manufacturer DroneShield, writes…
Today we publish the first of many profiles to run as part of @AuManufacturing’s Australia’s 50 most innovative manufacturers campaign. Brent Balinski speaks to EMVision CEO Scott Kirkland about a homegrown answer to the second-biggest killer in the world. With about a quarter of all people worldwide having suffered a stroke, it’s a super-prevalent, potentially…
